课题基金 / 基金详情

Novel collagen V-reactive natural Th17 cells in hypoxic pulmonary hypertension

Novel collagen V-reactive natural Th17 cells in hypoxic pulmonary hypertension
缺氧性肺动脉高压中新型胶原 V 反应性天然 Th17 细胞
批准号:
10267902
负责人:
Laura V Gonzalez Bosc
金额:
$37.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-24 至 2022-08-31

项目摘要

项目成果

Laura V Gonzalez Bosc的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hypoxic pulmonary hypertension (PH) is a progressive and often fatal consequence of chronic lung diseases, chronic exposure to high altitude and acute lung injury. We have demonstrated that TH17 cells, a pro-inflammatory T helper (TH) cell (CD4+) subset, are localized in the perivascular region of pulmonary arteries. These cells contribute to CH-induced PH. However, whether immunity to self- antigens contributes to disease progression is unknown. Type V collagen (col V) is normally sequestered within the lung interstitium and therefore, hidden from the immune system. Hypoxia could lead to exposure of col V and be a source of antigen. Col V cellular immunity contributes to TH17- dependent obliterative bronchiolitis post-lung transplant, atherosclerosis and interstitial lung fibrosis. However, it is unknown whether colV cellular immunity plays a role in the TH17 cell-dependent perivascular inflammation that contributes to CH-induced PH and the mechanism of TH17 cells homing. It is also unknown if this TH17 cells belong to the natural occurring (nTH17) subset. Therefore, we propose the novel hypothesis that nTH17-mediated PH develops as a result of increased col V-reactive nTH17 cells and reduced peripheral tolerance to col V. We also propose that this mechanism requires nTH17 cell trafficking to the perivascular region under the guidance of C-C motif chemokine ligand 2 (CCL2)/C-C chemokine receptor type 2 (CCR2) signaling. We will pursue the following aims: Specific Aim 1: To identify lung-associated self-antigens induced or exposed by CH. Hypothesis: Col V is a lung-associated self-antigen uncovered by CH that triggers nTH17 cell-mediated perivascular inflammation. Specific Aim 2: To identify the mechanism of nTH17 cell homing to the perivascular region in response to CH. Hypothesis: CCL2/CCR2 signaling drives nTH17 cell homing to the perivascular region in response to CH. Specific Aim 3: To determine the contribution of loss of peripheral tolerance to self-antigens in PH. Hypothesis: A loss in the normal balance between col V-reactive nTH17 cells and nTregs due to nTreg transition to an nTH17 phenotype contributes to the development of PH. Completion of these studies will identify the self-antigens or neo-antigens exposed by CH, determine triggers for nTH17 cell-homing to the pulmonary perivascular region, and the role of peripheral tolerance in this pathway. This groundbreaking study will also facilitate the development of therapies to selectively inhibit the generation of autoreactive T cells and their trafficking to the site of inflammation without affecting the capacity of the host to mount a proper inflammatory response to pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NFATc3 in chronic hypoxic pulmonary hypertension
  • 批准号:
    7839262
  • 项目类别:
  • 资助金额:
    $8.71万
  • 财政年份:
    2009
  • 负责人:
    Laura V Gonzalez Bosc
  • 依托单位:
NFATc3 in chronic hypoxic pulmonary hypertension
  • 批准号:
    7534997
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2007
  • 负责人:
    Laura V Gonzalez Bosc
  • 依托单位:
NFATc3 in chronic hypoxic pulmonary hypertension
  • 批准号:
    7746406
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2007
  • 负责人:
    Laura V Gonzalez Bosc
  • 依托单位:
NFATc3 in chronic hypoxic pulmonary hypertension
  • 批准号:
    7367250
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2007
  • 负责人:
    Laura V Gonzalez Bosc
  • 依托单位:
海外基金